1. Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine
- Author
-
Alexander Aichelburg, Andrea Steuer, Govinda S. Visvesvara, Helmut Prosch, Gedeon Perneczky, Horst Aspöck, Ojan Assadian, Julia Walochnik, and Norbert Vetter
- Subjects
Adult ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Miliary tuberculosis ,Tuberculosis ,Epidemiology ,Administration, Topical ,Phosphorylcholine ,Antiprotozoal Agents ,Administration, Oral ,lcsh:Medicine ,Acanthamoeba ,Tuberculous meningitis ,lcsh:Infectious and parasitic diseases ,Immunocompromised Host ,Skin Ulcer ,Animals ,Humans ,Medicine ,lcsh:RC109-216 ,Granulomatous amoebic encephalitis ,Miltefosine ,Granuloma ,biology ,Tuberculosis, Miliary ,business.industry ,immunocompromised non–HIV-infected patient ,granulomatous Acanthamoeba encephalitis (GAE) ,lcsh:R ,dispatch ,Amebiasis ,biology.organism_classification ,medicine.disease ,Dermatology ,Treatment Outcome ,Infectious Diseases ,tuberculosis ,Immunology ,Encephalitis ,business ,miltefosine ,medicine.drug - Abstract
We report on an HIV-negative but immunocompromised patient with disseminated acanthamoebiasis, granulomatous amoebic encephalitis, and underlying miliary tuberculosis and tuberculous meningitis. The patient responded favorably to treatment with miltefosine, an alkylphosphocholine. The patient remained well with no signs of infection 2 years after treatment cessation.
- Published
- 2008